We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Skip to main content
SpringerLink
Log in

Updates from NZ Medsafe

  • News item
  • Published:
Reactions Weekly Aims and scope

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Medsafe.High dose simvastatin increases myopathy risk. Prescriber Update 32: 23, No. 3, Sep 2011. Available from: URL: http://www.medsafe.govt.nz

  2. Medsafe.Reminder: Keeping an eye on bisphosphonates. Prescriber Update 32: 24, No. 3, Sep 2011. Available from: URL: http://www.medsafe.govt.nz

  3. Medsafe.Proton pump inhibitors and interstitial nephritis. Prescriber Update 32: 25, No. 3, Sep 2011. Available from: URL: http://www.medsafe.govt.nz

  4. Medsafe.Updated advice: ceftriaxone and calcium precipitation. Prescriber Update 32: 26, No. 3, Sep 2011. Available from: URL: http://www.medsafe.govt.nz

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Updates from NZ Medsafe. React. Wkly. 1380, 2 (2011). https://doi.org/10.2165/00128415-201113800-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113800-00002

Keywords

Search

Navigation